205 related articles for article (PubMed ID: 31657679)
41. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
42. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
[TBL] [Abstract][Full Text] [Related]
43. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells.
Hossain JA; Ystaas LR; Mrdalj J; Välk K; Riecken K; Fehse B; Bjerkvig R; Grønli J; Miletic H
J Gene Med; 2016 Sep; 18(9):234-43. PubMed ID: 27490042
[TBL] [Abstract][Full Text] [Related]
44. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
45. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
[TBL] [Abstract][Full Text] [Related]
46. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma.
Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X
Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091
[TBL] [Abstract][Full Text] [Related]
47. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
[TBL] [Abstract][Full Text] [Related]
48. Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma.
Hossain JA; Latif MA; Ystaas LAR; Ninzima S; Riecken K; Muller A; Azuaje F; Joseph JV; Talasila KM; Ghimire J; Fehse B; Bjerkvig R; Miletic H
Neuro Oncol; 2019 Jul; 21(7):890-900. PubMed ID: 30958558
[TBL] [Abstract][Full Text] [Related]
49. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing.
Adachi M; Sampath J; Lan LB; Sun D; Hargrove P; Flatley R; Tatum A; Edwards MZ; Wezeman M; Matherly L; Drake R; Schuetz J
J Biol Chem; 2002 Oct; 277(41):38998-9004. PubMed ID: 12105214
[TBL] [Abstract][Full Text] [Related]
50. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
51. Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.
Kuriyama S; Mitoro A; Yamazaki M; Tsujinoue H; Nakatani T; Akahane T; Toyokawa Y; Kojima H; Okamoto S; Fukui H
Scand J Gastroenterol; 1999 Oct; 34(10):1033-41. PubMed ID: 10563675
[TBL] [Abstract][Full Text] [Related]
52. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
[TBL] [Abstract][Full Text] [Related]
53. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy].
Zhang L; Liu T; Cui Q; Gao J
Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559
[TBL] [Abstract][Full Text] [Related]
54. Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system.
Zhang Z; Lin J; Chu J; Ma Y; Zeng S; Luo Q
J Biomed Opt; 2008; 13(3):031209. PubMed ID: 18601533
[TBL] [Abstract][Full Text] [Related]
55. Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer.
Wang J; Lu XX; Chen DZ; Li SF; Zhang LS
World J Gastroenterol; 2004 Feb; 10(3):400-3. PubMed ID: 14760766
[TBL] [Abstract][Full Text] [Related]
56. Role of Equilibrative Nucleobase Transporter 1/SLC43A3 as a Ganciclovir Transporter in the Induction of Cytotoxic Effect of Ganciclovir in a Suicide Gene Therapy with Herpes Simplex Virus Thymidine Kinase.
Furukawa J; Inoue K; Ohta K; Yasujima T; Mimura Y; Yuasa H
J Pharmacol Exp Ther; 2017 Jan; 360(1):59-68. PubMed ID: 27807008
[TBL] [Abstract][Full Text] [Related]
57. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.
Martinez-Quintanilla J; Bhere D; Heidari P; He D; Mahmood U; Shah K
Stem Cells; 2013 Aug; 31(8):1706-14. PubMed ID: 23389839
[TBL] [Abstract][Full Text] [Related]
59. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models.
Chen Y; Huang H; Yao C; Su F; Guan W; Yan S; Ni Z
Cancer Med; 2016 Sep; 5(9):2477-86. PubMed ID: 27366865
[TBL] [Abstract][Full Text] [Related]
60. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
Wang X; Li L; Feng K; Bai L; Pei X
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
